{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:58:35Z","timestamp":1793858315585,"version":"4.6.1"},"reference-count":113,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disorder marked by autoantibody-mediated dysfunction at the neuromuscular junction, resulting in fluctuating muscle weakness. The pathogenesis of MG involves a complex interplay between genetic predisposition, environmental factors, and immune system dysregulation. Among these, the innate immune system, particularly Toll-like receptors (TLRs), has emerged as a critical player in disease progression by influencing both innate and adaptive immunity. TLRs are a family of pattern recognition receptors (PRRs) that detect pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs), triggering immune responses. Dysregulation of TLRs expression and signaling in MG has been implicated in chronic inflammation, breakdown of immune tolerance, and activation of autoreactive T and B cells. Overexpression of specific TLRs, such as TLR4 and TLR9, has been reported in MG patients, particularly in thymic tissues and peripheral immune cells, correlating with increased pro-inflammatory cytokine production and autoantibody generation. These aberrant responses contribute to the autoimmune cascade that underlies MG. Emerging evidence highlights the therapeutic potential of targeting TLRs pathways in MG. Strategies include using TLRs antagonists, modulating downstream signaling pathways, and leveraging epigenetic regulators to normalize TLRs activity. This review examines the role of TLRs in MG by exploring their expression profiles, their involvement in inflammatory signaling pathways, their impact on the adaptive immune system, and their potential as therapeutic targets. A better understanding of the role of TLRs in MG pathogenesis could open new avenues for modulating immune responses and precision therapies targeting the innate immune system.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1624957","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T06:26:49Z","timestamp":1766125609000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Toll-like receptors and their role in the pathogenesis of myasthenia gravis: a comprehensive review"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiaoxiao","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e14568","DOI":"10.1111\/cns.14568","article-title":"Thymoma-associated autoimmune encephalitis with myasthenia gravis: Case series and literature review","volume":"30","author":"Su","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2108672119","article-title":"Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study","volume":"119","author":"Chia","year":"2022","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcad225","article-title":"Environmental factors affecting the risk of generalization for ocular-onset myasthenia gravis: a nationwide cohort study","volume":"117","author":"Wang","year":"2024","journal-title":"Qjm"},{"key":"B7","doi-asserted-by":"publisher","first-page":"102800","DOI":"10.1016\/j.autrev.2021.102800","article-title":"The role of innate immunity in myasthenia gravis","volume":"20","author":"Zhao","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2014.05.001","article-title":"Myasthenia Gravis: paradox versus paradigm in autoimmunity","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nri3446","article-title":"The history of Toll-like receptors - redefining innate immunity","volume":"13","author":"O'Neill","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.03.014","article-title":"Control of adaptive immunity by pattern recognition receptors","volume":"57","author":"Carroll","year":"2024","journal-title":"Immunity"},{"key":"B12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41584-020-00544-4","article-title":"Toll-like receptor signalling in B cells during systemic lupus erythematosus","volume":"17","author":"Fillatreau","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-019-08742-z","article-title":"Toll-like receptors, infections, and rheumatoid arthritis","volume":"58","author":"Arleevskaya","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneph.2015.175","article-title":"Innate immunity in diabetes and diabetic nephropathy","volume":"12","author":"Wada","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002302","article-title":"The Drosophila Toll signaling pathway","volume":"186","author":"Valanne","year":"2011","journal-title":"J Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.smim.2006.12.004","article-title":"TLR signaling","volume":"19","author":"Kawai","year":"2007","journal-title":"Semin Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00386","article-title":"TLR-dependent human mucosal epithelial cell responses to microbial pathogens","volume":"5","author":"McClure","year":"2014","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061374","article-title":"Toll-like receptor signaling in the establishment and function of the immune system","volume":"10","author":"Aluri","year":"2021","journal-title":"Cells"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1006\/bcmd.1998.0201","article-title":"Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region","volume":"24","author":"Poltorak","year":"1998","journal-title":"Blood Cells Mol Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/35074106","article-title":"The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5","volume":"410","author":"Hayashi","year":"2001","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.09.008","article-title":"Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide","volume":"130","author":"Jin","year":"2007","journal-title":"Cell"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.161293498","article-title":"Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition","volume":"98","author":"Bauer","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nri2079","article-title":"The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling","volume":"7","author":"O'Neill","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.smim.2003.10.003","article-title":"TLR signaling pathways","volume":"16","author":"Takeda","year":"2004","journal-title":"Semin Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae973","article-title":"Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics","volume":"53","author":"Jiang","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e24370","DOI":"10.1371\/journal.pone.0024370","article-title":"Association of inherited variation in Toll-like receptor genes with Malignant melanoma susceptibility and survival","volume":"6","author":"Gast","year":"2011","journal-title":"PloS One"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e12988","DOI":"10.1111\/sji.12988","article-title":"TLR10: Insights, controversies and potential utility as a therapeutic target","volume":"93","author":"Su","year":"2021","journal-title":"Scand J Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"15789","DOI":"10.1038\/s41598-024-66410-5","article-title":"Human red blood cells express the RNA sensor TLR7","volume":"14","author":"Metthew Lam","year":"2024","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1044662","article-title":"MyD88-dependent signaling drives toll-like receptor-induced trained immunity in macrophages","volume":"13","author":"Owen","year":"2022","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1631\/jzus.B2000808","article-title":"Toll-like receptor 3 (TLR3) regulation mechanisms and roles in antiviral innate immune responses","volume":"22","author":"Chen","year":"2021","journal-title":"J Zhejiang Univ Sci B"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2006.06.005","article-title":"Toll-like receptors on regulatory T cells: expanding immune regulation","volume":"27","author":"Sutmuller","year":"2006","journal-title":"Trends Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2012.61","article-title":"TLR signaling in B-cell development and activation","volume":"10","author":"Hua","year":"2013","journal-title":"Cell Mol Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/art.21273","article-title":"RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3","volume":"52","author":"Brentano","year":"2005","journal-title":"Arthritis Rheumatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jaut.2013.12.013","article-title":"Innate immunity in myasthenia gravis thymus: pathogenic effects of Toll-like receptor 4 signaling on autoimmunity","volume":"52","author":"Cordiglieri","year":"2014","journal-title":"J Autoimmun"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189801","article-title":"A20 inhibits LPS-induced inflammation by regulating TRAF6 polyubiquitination in rainbow trout","volume":"22","author":"Jang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.558341","article-title":"SOCS proteins participate in the regulation of innate immune response caused by viruses","volume":"11","author":"Huang","year":"2020","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1093208","article-title":"Toll-like receptors 7 and 9 regulate the proliferation and differentiation of B cells in systemic lupus erythematosus","volume":"14","author":"Wen","year":"2023","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/nyas.13534","article-title":"Toll-like receptors 7 and 9 in myasthenia gravis thymus: amplifiers of autoimmunity","volume":"1413","author":"Cavalcante","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00142","article-title":"miR-146a in myasthenia gravis thymus bridges innate immunity with autoimmunity and is linked to therapeutic effects of corticosteroids","volume":"11","author":"Bortone","year":"2020","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2015.12.007","article-title":"Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection","volume":"221","author":"Cavalcante","year":"2016","journal-title":"Immunobiology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1146\/annurev.immunol.23.021704.115601","article-title":"A central role for central tolerance","volume":"24","author":"Kyewski","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1126\/science.1075958","article-title":"Projection of an immunological self shadow within the thymus by the aire protein","volume":"298","author":"Anderson","year":"2002","journal-title":"Science"},{"key":"B45","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26590","article-title":"Central role of macrophages and nucleic acid release in myasthenia gravis thymus","volume":"93","author":"Payet","year":"2023","journal-title":"Ann Neurol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041328","article-title":"Loss of Bim increases T cell production and function in interleukin 7 receptor-deficient mice","volume":"200","author":"Pellegrini","year":"2004","journal-title":"J Exp Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2011.06.003","article-title":"Regulatory T cell lineage commitment in the thymus","volume":"23","author":"Klein","year":"2011","journal-title":"Semin Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-012-9526-6","article-title":"Possible involvement of toll-like receptors in the pathogenesis of myasthenia gravis","volume":"36","author":"Wang","year":"2013","journal-title":"Inflammation"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2012.06825.x","article-title":"Further developments with antisense treatment for myasthenia gravis","volume":"1275","author":"Sussman","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1405.019","article-title":"Regulatory and pathogenic mechanisms in human autoimmune myasthenia gravis","volume":"1132","author":"Le Panse","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-016-8549-4","article-title":"Review on toll-like receptor activation in myasthenia gravis: application to the development of new experimental models","volume":"52","author":"Robinet","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e919150","DOI":"10.12659\/MSM.919150","article-title":"Effect of grilled nux vomica on differential RNA expression profile of gastrocnemius muscle and toll\u2212Like receptor 4 (TLR-4)\/nuclear factor kappa B (NF-\u03baB) signaling in experimental autoimmune myasthenia gravis rats","volume":"26","author":"Jiang","year":"2020","journal-title":"Med Sci Monit"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202311_34309","article-title":"TLR4-MyD88-NF-\u03baB signaling imbalances Th17 and Treg cells in thymoma with myasthenia gravis","volume":"27","author":"Zhang","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.4014\/jmb.2407.07025","article-title":"Ammonia exposure-induced immunological damage in chicken lymphoid organs via TLR-7\/MYD88\/NF-\u03baB signaling pathway and NLRP3 inflammasome activation","volume":"34","author":"Rahman","year":"2024","journal-title":"J Microbiol Biotechnol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"9839","DOI":"10.1038\/s41467-024-53595-6","article-title":"Genome-wide meta-analysis of myasthenia gravis uncovers new loci and provides insights into polygenic prediction","volume":"15","author":"Braun","year":"2024","journal-title":"Nat Commun"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e23679","DOI":"10.1097\/MD.0000000000023679","article-title":"Therapeutic efficacy and immunoregulatory effect of Qiangji Jianli Capsule for patients with myasthenia gravis: Study protocol for a series of randomized, controlled N-of-1 trials","volume":"99","author":"Weng","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"B58","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.neulet.2013.09.014","article-title":"Altered expression of miR-146a in myasthenia gravis","volume":"555","author":"Lu","year":"2013","journal-title":"Neurosci Lett"},{"key":"B59","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S0165-5728(97)00161-6","article-title":"Polymorphisms in IL-1beta and IL-1 receptor antagonist genes are associated with myasthenia gravis","volume":"81","author":"Huang","year":"1998","journal-title":"J Neuroimmunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1474-4422(24)00528-3","article-title":"The role of IL-6 blockers in myasthenia gravis","volume":"24","author":"Waheed","year":"2025","journal-title":"Lancet Neurol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-011-6036-7","article-title":"Elevated serum level of interleukin-32\u03b1 in the patients with myasthenia gravis","volume":"258","author":"Na","year":"2011","journal-title":"J Neurol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.12.014","article-title":"Follicular dendritic cell activation by TLR ligands promotes autoreactive B cell responses","volume":"46","author":"Das","year":"2017","journal-title":"Immunity"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23869","article-title":"West nile virus infection and myasthenia gravis","volume":"49","author":"Leis","year":"2014","journal-title":"Muscle Nerve"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27919","article-title":"COVID-19 infection in myasthenia gravis: Clinical course and outcomes","volume":"68","author":"Thomas","year":"2023","journal-title":"Muscle Nerve"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/nri3795","article-title":"The generation of antibody-secreting plasma cells","volume":"15","author":"Nutt","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1365-2567.2004.01781.x","article-title":"Differential production of cytokines, reactive oxygen and nitrogen by bovine macrophages and dendritic cells stimulated with Toll-like receptor agonists","volume":"111","author":"Werling","year":"2004","journal-title":"Immunology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.imlet.2018.03.010","article-title":"Effects of Toll-like receptor 4 on \u03b22-glycoprotein I-induced splenic T cell subsets differentiation","volume":"198","author":"He","year":"2018","journal-title":"Immunol Lett"},{"key":"B68","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41467-022-28172-4","article-title":"Neutrophil extracellular traps and their histones promote Th17 cell differentiation directly via TLR2","volume":"13","author":"Wilson","year":"2022","journal-title":"Nat Commun"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-019-01146-9","article-title":"T helper 17 (Th17) cells and interleukin-17 (IL-17) in cancer","volume":"42","author":"Chang","year":"2019","journal-title":"Arch Pharm Res"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2007.09.002","article-title":"Signaling to NF-kappaB by toll-like receptors","volume":"13","author":"Kawai","year":"2007","journal-title":"Trends Mol Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2016.00050","article-title":"Gain-of-function mutations in the toll-like receptor pathway: TPL2-mediated ERK1\/ERK2 MAPK activation, a path to tumorigenesis in lymphoid neoplasms","volume":"4","author":"Rousseau","year":"2016","journal-title":"Front Cell Dev Biol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01373","article-title":"T(H)17 cell and epithelial cell crosstalk during inflammatory bowel disease and carcinogenesis","volume":"8","author":"Kempski","year":"2017","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202049123","article-title":"Mechanisms of exTreg induction","volume":"51","author":"Saxena","year":"2021","journal-title":"Eur J Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201040391","article-title":"IL-6: regulator of Treg\/Th17 balance","volume":"40","author":"Kimura","year":"2010","journal-title":"Eur J Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-018-0004-4","article-title":"When worlds collide: Th17 and Treg cells in cancer and autoimmunity","volume":"15","author":"Knochelmann","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jaut.2019.02.001","article-title":"Counter-regulation of regulatory T cells by autoreactive CD8(+) T cells in rheumatoid arthritis","volume":"99","author":"Cammarata","year":"2019","journal-title":"J Autoimmun"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2011.05.006","article-title":"Complement and cytokine based therapeutic strategies in myasthenia gravis","volume":"37","author":"T\u00fcz\u00fcn","year":"2011","journal-title":"J Autoimmun"},{"key":"B78","doi-asserted-by":"publisher","first-page":"115957","DOI":"10.1016\/j.carbpol.2020.115957","article-title":"Cultured Cordyceps sinensis polysaccharides modulate intestinal mucosal immunity and gut microbiota in cyclophosphamide-treated mice","volume":"235","author":"Ying","year":"2020","journal-title":"Carbohydr Polym"},{"key":"B79","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13148-017-0385-8","article-title":"Epigenetic regulation of inflammation in localized aggressive periodontitis","volume":"9","author":"Shaddox","year":"2017","journal-title":"Clin Epigenetics"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-015-8473-z","article-title":"Toll-like receptor pathways in autoimmune diseases","volume":"50","author":"Chen","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.05.027","article-title":"Complete sequence analysis of human toll-like receptor 3 gene in natural killer cells of multiple sclerosis patients","volume":"33","author":"Deeba","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314549792","article-title":"Association of TLR4 (D299G, T399I), TLR9 -1486T>C, TIRAP S180L and TNF-\u03b1 promoter (-1031, -863, -857) polymorphisms with risk for systemic lupus erythematosus among South Indians","volume":"24","author":"Rupasree","year":"2015","journal-title":"Lupus"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07220-7","article-title":"Formation of memory assemblies through the DNA-sensing TLR9 pathway","volume":"628","author":"Jovasevic","year":"2024","journal-title":"Nature"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00292","article-title":"TLR9 ligand (CpG oligodeoxynucleotide) induces CLL B-cells to differentiate into CD20(+) antibody-secreting cells","volume":"5","author":"Ghamlouch","year":"2014","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-15030","article-title":"Association between copy number variations of TLR7 and ocular beh\u00e7et's disease in a chinese han population","volume":"56","author":"Fang","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105351","article-title":"Human and murine toll-like receptor-driven disease in systemic lupus erythematosus","volume":"25","author":"von Hofsten","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179627","article-title":"Metal Ion Periplasmic-Binding Protein YfeA of Glaesserella parasuis Induces the Secretion of Pro-Inflammatory Cytokines of Macrophages via MAPK and NF-\u03baB Signaling through TLR2 and TLR4","volume":"23","author":"Yang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13491","article-title":"METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide-induced inflammatory response in human dental pulp cells","volume":"22","author":"Feng","year":"2018","journal-title":"J Cell Mol Med"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2017.05.011","article-title":"The effects of TLR3, TRIF and TRAF3 SNPs and interactions with environmental factors on type 2 diabetes mellitus and vascular complications in a Han Chinese population","volume":"626","author":"Zhou","year":"2017","journal-title":"Gene"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2400054","article-title":"Both IRAK3 and IRAK1 activate the myD88-TRAF6 pathway in zebrafish","volume":"213","author":"Weng","year":"2024","journal-title":"J Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.538009","article-title":"Interleukin-1 receptor-associated kinase-2 genetic variant rs708035 increases NF-\u03baB activity through promoting TRAF6 ubiquitination","volume":"289","author":"Zhang","year":"2014","journal-title":"J Biol Chem"},{"key":"B92","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/s13071-019-3615-4","article-title":"DNA methylation and hydroxymethylation profiles reveal possible role of highly methylated TLR signaling on Fasciola gigantica excretory\/secretory products (FgESPs) modulation of buffalo dendritic cells","volume":"12","author":"Mei","year":"2019","journal-title":"Parasit Vectors"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005081","article-title":"Identification of 2 DNA methylation subtypes of Waldenstr\u00f6m macroglobulinemia with plasma and memory B-cell features","volume":"136","author":"Roos-Weil","year":"2020","journal-title":"Blood"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1016\/j.celrep.2020.02.007","article-title":"Class IIa histone deacetylases drive toll-like receptor-inducible glycolysis and macrophage inflammatory responses via pyruvate kinase M2","volume":"30","author":"Das Gupta","year":"2020","journal-title":"Cell Rep"},{"key":"B95","doi-asserted-by":"publisher","first-page":"111784","DOI":"10.1016\/j.biopha.2021.111784","article-title":"Interaction between non-coding RNAs and Toll-like receptors","volume":"140","author":"Ghafouri-Fard","year":"2021","journal-title":"BioMed Pharmacother"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312964","article-title":"A review on the role of non-coding RNAs in the pathogenesis of myasthenia gravis","volume":"22","author":"Ghafouri-Fard","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2284","article-title":"Genetic variation in Toll-like receptors and disease susceptibility","volume":"13","author":"Netea","year":"2012","journal-title":"Nat Immunol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.actbio.2016.11.034","article-title":"Adsorbed Fibrinogen stimulates TLR-4 on monocytes and induces BMP-2 expression","volume":"49","author":"Oliveira","year":"2017","journal-title":"Acta Biomater"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006101162","article-title":"Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus","volume":"18","author":"Pawar","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"109130","DOI":"10.1016\/j.intimp.2022.109130","article-title":"Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach","volume":"111","author":"Aliyu","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq031","article-title":"Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents","volume":"49","author":"Horiuchi","year":"2010","journal-title":"Rheumatol (Oxford)"},{"key":"B102","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s10875-025-01953-4","article-title":"S100A4 induces neutrophilic inflammation in chronic rhinosinusitis with nasal polyps via TLR4 pathway","volume":"45","author":"Tu","year":"2025","journal-title":"J Clin Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S551388","article-title":"The EZH2 inhibitor GSK126 alleviates thromboinflammation in deep vein thrombosis by suppressing TLR4 signaling via H3K27me3 modulation","volume":"18","author":"Zhou","year":"2025","journal-title":"J Inflammation Res"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1172\/JCI162291","article-title":"Effect of acute TLR4 inhibition on insulin resistance in humans","volume":"132","author":"Liang","year":"2022","journal-title":"J Clin Invest"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061562","article-title":"Eritoran attenuates hepatic inflammation and fibrosis in mice with chronic liver injury","volume":"10","author":"Hsieh","year":"2021","journal-title":"Cells"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.07.122","article-title":"A phase 2, double-blinded, placebo-controlled trial of toll-like receptor 7\/8\/9 antagonist, IMO-8400, in dermatomyositis","volume":"84","author":"Kim","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxaf046","article-title":"Anti-human TLR7 antibody for therapeutic intervention in systemic lupus erythematosus","author":"Fukui","year":"2025","journal-title":"Int Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaf216","article-title":"Plasmacytoid dendritic cells modulate the production of mucosal IgA in IgA nephropathy","author":"Fukao","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvy209","article-title":"Inhibition of TLR9-NF-\u03baB-mediated sterile inflammation improves pressure overload-induced right ventricular dysfunction in rats","volume":"115","author":"Yoshida","year":"2019","journal-title":"Cardiovasc Res"},{"key":"B110","doi-asserted-by":"publisher","first-page":"112157","DOI":"10.1016\/j.yexcr.2020.112157","article-title":"The MyD88 inhibitor TJ-M2010\u20132 suppresses proliferation, migration and invasion of breast cancer cells by regulating MyD88\/GSK-3\u03b2 and MyD88\/NF-\u03baB signalling pathways","volume":"394","author":"Liu","year":"2020","journal-title":"Exp Cell Res"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201242792","article-title":"IRF-5 and NF-\u03baB p50 co-regulate IFN-\u03b2 and IL-6 expression in TLR9-stimulated human plasmacytoid dendritic cells","volume":"43","author":"Steinhagen","year":"2013","journal-title":"Eur J Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2019.1661430","article-title":"Inhibition of anti-viral responses in intestinal epithelial cells by epigenetic modifying drugs is mediated by a reduction in viral pattern recognition receptor expression and activity","volume":"41","author":"Hennessy","year":"2019","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"e2307798120","DOI":"10.1073\/pnas.2307798120","article-title":"Recent advances in nanoparticulate RNA delivery systems","volume":"121","author":"Witten","year":"2024","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1624957\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T06:26:52Z","timestamp":1766125612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1624957\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":113,"alternative-id":["10.3389\/fimmu.2025.1624957"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1624957","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"article-number":"1624957"}}